跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Foskina B
Approved
STANDARD
Foskina B
Glenmark Pharmaceuticals Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
4558c7ea81543207
Company
Glenmark Pharmaceuticals Ltd.
Type
Standard
Approval Details
Approval Id
4558c7ea81543207
Drug Approval Philippines Name
Foskina B
Product Name
Foskina B
Registration Number
DRP-8422
Brand Name
Foskina B
Generic Name
Mupirocin + Betamethasone (as Dipropionate)
Dosage Form
Ointment
Dosage Strength
20 mg (2%)/ 500 mcg (0.05%) per gram
Manufacturer
Glenmark Pharmaceuticals Ltd.
Importer
Glenmark Philippines Ltd.
Distributor
Glenmark Philippines Ltd.
Issuance Date
27 August 2020
Expiry Date
04 January 2026
Pharmacologic Category
Antibacterial/ Topical Corticosteroid
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
4558c7ea81543207
Type
Standard
Back to Philippines FDA Approvals
Foskina B - Philippines FDA Drug Approval Details